We are delighted to support the further growth of Amoena, a portfolio company of Halder

Amoena, founded in 1975 and headquartered in Raubling, Germany, is the global leader in medical breast care products. With over 375 employees, Amoena supports breast cancer patients with the broadest portfolio of medically certified products, including silicone breast forms, recovery care, lymph products, and specialized apparel. Known for quality and innovation, Amoena has a sales network in every relevant market worldwide.

Apera, together with OLB, provided the financing, comprising a Unitranche Loan in combination with Term Loan and RCF Facilities.

Mathias Fackelmeyer, Partner at Halder, said: "We are looking forward to working with Apera and OLB. Their expertise in structuring a tailored financing solution is instrumental in supporting our strategic growth objectives for Amoena in this highly attractive segment".

Benjamin Schall, Partner at Apera, said: “We are very pleased to complete our first transaction with Halder and are very excited to accompanying Amoena on its growth path in the future. We also look forward to developing a fruitful and trustful partnership with both Halder and the Company.”

You can download a PDF of the press release here.

About Apera 

Apera is a pan-European mid-market private debt investor operating in the UK, the DACH region, the Nordic region, France and Benelux. The firm develops long-term partnerships with private equity investors, SME borrowers, and advisors by providing tailored financial solutions that meet both the operational needs and growth objectives of clients, whilst producing attractive returns. Apera is focused on bringing a new standard of transparency to the private debt market. Apera currently has €4.0bn assets under management, with offices in London, Paris, Munich and Luxembourg.